Joined
·
6,190 Posts
<div style="margin:20px;margin-top:5px;">
<div class="smallfont" style="margin-bottom:2px;">Quote:</div>
<table border="0" cellpadding="6" cellspacing="0" width="99%"><tr><td class="alt2" style="border:1px inset;">Specific recommendations for the use of varicella vaccines are as follows:<br><br>
* For children aged 12 months or older, adolescents, and adults without evidence of immunity, two 0.5-mL doses of varicella vaccine should be given subcutaneously. The recommended minimum interval between the 2 doses is 3 months for children aged 12 months to 12 years. However, if the second dose was given more than 28 days after the first dose, the second dose does not have to be repeated. For persons aged 13 years and older, 4 weeks is the recommended minimum interval.<br><br>
* Single-antigen varicella vaccine is approved for use in healthy persons aged 12 months or older, whereas combination MMRV vaccine for simultaneous vaccination against MMRV is approved for use in healthy children aged 12 months to 12 years. Whenever any components of the combination vaccine are indicated and the other components are not contraindicated, the MMRV vaccine or other licensed combination vaccines is preferred over separate injection of equivalent component vaccines.<br><br>
* Routine vaccination schedules for young children are as follows: all healthy children should receive their first dose of varicella-containing vaccine at age 12 to 15 months. A second dose of varicella vaccine is recommended for all children aged 4 to 6 years before entering school, but it may be given earlier as long as the interval between the first and second dose is more than 3 months. Because of the risk for VZV transmission in schools, all children entering school should have received 2 doses of varicella-containing vaccine or have other evidence of immunity to varicella.<br><br>
* Routine vaccination schedules for adolescents and students are as follows: persons aged 13 years or older without evidence of varicella immunity should be given two 0.5-mL doses of single-antigen varicella vaccine subcutaneously, 4 to 8 weeks apart. If more than 8 weeks elapse after the first dose, the second dose may be given without restarting the schedule. The MMRV vaccine is not licensed for use in anyone aged 13 years or older. All students should be evaluated for varicella immunity, and those without such evidence should routinely receive 2 doses of single-antigen varicella vaccine 4 to 8 weeks apart.<br><br>
* All healthy adults should be evaluated for varicella immunity, and those without such evidence should be given 2 doses of single-antigen varicella vaccine 4 to 8 weeks apart. Special consideration for vaccination should be given to adults without evidence of immunity who might be at increased risk for exposure or transmission.<br><br>
* Second-dose, catch-up varicella vaccination is recommended for children, adolescents, and adults previously given 1 dose to improve individual protection against varicella and to more rapidly control school outbreaks. Catch-up vaccination may be given during routine healthcare provider visits, such as the recommended health maintenance visit at age 11 to 12 years, and through school and college entry requirements. Although the recommended minimum interval between the first dose and the catch-up second dose is 3 months for children aged 12 years or younger and 4 weeks for persons aged 13 years or older, the catch-up second dose may be given at any interval longer than the minimum recommended interval.<br><br>
* Pregnant women should undergo prenatal evaluation for evidence of varicella immunity. Because of the potentially devastating sequelae of varicella infection during pregnancy, birth before 1980 is not considered evidence of immunity for pregnant women. After delivery or pregnancy termination, women without evidence of varicella immunity should be given the first dose of vaccine before hospital discharge and the second dose 4 to 8 weeks later at the postpartum visit.</td>
</tr></table></div>
<a href="http://www.medscape.com/viewarticle/558838?src=mp" target="_blank">http://www.medscape.com/viewarticle/558838?src=mp</a><br><br><img alt="" class="inlineimg" src="http://www.mothering.com/discussions/images/smilies/banghead.gif" style="border:0px solid;" title="banghead">
<div class="smallfont" style="margin-bottom:2px;">Quote:</div>
<table border="0" cellpadding="6" cellspacing="0" width="99%"><tr><td class="alt2" style="border:1px inset;">Specific recommendations for the use of varicella vaccines are as follows:<br><br>
* For children aged 12 months or older, adolescents, and adults without evidence of immunity, two 0.5-mL doses of varicella vaccine should be given subcutaneously. The recommended minimum interval between the 2 doses is 3 months for children aged 12 months to 12 years. However, if the second dose was given more than 28 days after the first dose, the second dose does not have to be repeated. For persons aged 13 years and older, 4 weeks is the recommended minimum interval.<br><br>
* Single-antigen varicella vaccine is approved for use in healthy persons aged 12 months or older, whereas combination MMRV vaccine for simultaneous vaccination against MMRV is approved for use in healthy children aged 12 months to 12 years. Whenever any components of the combination vaccine are indicated and the other components are not contraindicated, the MMRV vaccine or other licensed combination vaccines is preferred over separate injection of equivalent component vaccines.<br><br>
* Routine vaccination schedules for young children are as follows: all healthy children should receive their first dose of varicella-containing vaccine at age 12 to 15 months. A second dose of varicella vaccine is recommended for all children aged 4 to 6 years before entering school, but it may be given earlier as long as the interval between the first and second dose is more than 3 months. Because of the risk for VZV transmission in schools, all children entering school should have received 2 doses of varicella-containing vaccine or have other evidence of immunity to varicella.<br><br>
* Routine vaccination schedules for adolescents and students are as follows: persons aged 13 years or older without evidence of varicella immunity should be given two 0.5-mL doses of single-antigen varicella vaccine subcutaneously, 4 to 8 weeks apart. If more than 8 weeks elapse after the first dose, the second dose may be given without restarting the schedule. The MMRV vaccine is not licensed for use in anyone aged 13 years or older. All students should be evaluated for varicella immunity, and those without such evidence should routinely receive 2 doses of single-antigen varicella vaccine 4 to 8 weeks apart.<br><br>
* All healthy adults should be evaluated for varicella immunity, and those without such evidence should be given 2 doses of single-antigen varicella vaccine 4 to 8 weeks apart. Special consideration for vaccination should be given to adults without evidence of immunity who might be at increased risk for exposure or transmission.<br><br>
* Second-dose, catch-up varicella vaccination is recommended for children, adolescents, and adults previously given 1 dose to improve individual protection against varicella and to more rapidly control school outbreaks. Catch-up vaccination may be given during routine healthcare provider visits, such as the recommended health maintenance visit at age 11 to 12 years, and through school and college entry requirements. Although the recommended minimum interval between the first dose and the catch-up second dose is 3 months for children aged 12 years or younger and 4 weeks for persons aged 13 years or older, the catch-up second dose may be given at any interval longer than the minimum recommended interval.<br><br>
* Pregnant women should undergo prenatal evaluation for evidence of varicella immunity. Because of the potentially devastating sequelae of varicella infection during pregnancy, birth before 1980 is not considered evidence of immunity for pregnant women. After delivery or pregnancy termination, women without evidence of varicella immunity should be given the first dose of vaccine before hospital discharge and the second dose 4 to 8 weeks later at the postpartum visit.</td>
</tr></table></div>
<a href="http://www.medscape.com/viewarticle/558838?src=mp" target="_blank">http://www.medscape.com/viewarticle/558838?src=mp</a><br><br><img alt="" class="inlineimg" src="http://www.mothering.com/discussions/images/smilies/banghead.gif" style="border:0px solid;" title="banghead">